Change management when introducing AI into established release processes Change management when introducing AI into established release processes Regulatory Affairs Context As the pharmaceutical and biotechnology industries continue to evolve, the integration of Artificial Intelligence (AI) tools into quality systems has become increasingly prevalent. AI plays a transformative role in batch release processes and Real-Time Release Testing (RTRT), necessitating a comprehensive understanding of the regulatory landscape governing these changes. This article outlines the key regulations and guidelines relevant to AI implementation within established release procedures, directing focus toward US (FDA), EU (EMA), and UK (MHRA) regulations. Legal/Regulatory Basis The adoption…

Linking AI RTRT Models to Specifications and Control Strategy Narratives Linking AI RTRT Models to Specifications and Control Strategy Narratives This article provides a comprehensive regulatory explainer manual on effectively integrating AI tools for batch release and Real-Time Release Testing (RTRT) within quality systems, specifically for professionals in regulatory affairs, quality assurance, and batch disposition processes in the pharmaceutical and biotechnology sectors. As the industry evolves through advanced manufacturing technologies, compliance with regulatory expectations from the FDA, EMA, and MHRA becomes paramount. Context Real-Time Release Testing (RTRT) facilitates the timely assessment of product quality, creating significant advantages for manufacturers aiming…

Global agency perspectives on AI in RTRT and continuous manufacturing Global Agency Perspectives on AI in RTRT and Continuous Manufacturing As the pharmaceutical industry advances towards more efficient and responsive manufacturing processes, the integration of Artificial Intelligence (AI) tools in quality assurance (QA) practices, specifically in batch release and Real-Time Release Testing (RTRT), has become increasingly relevant. This article aims to explore the regulatory framework surrounding AI tools in RTRT and continuous manufacturing from a global perspective, providing insights critical for regulatory affairs (RA) professionals. Regulatory Affairs Context The utilization of AI tools for batch release and RTRT offers the…

Scenario Planning for AI Model Failure and Fall Back Release Approaches Scenario Planning for AI Model Failure and Fall Back Release Approaches In the evolving landscape of pharmaceutical and biotech manufacturing, the integration of AI tools for batch release and Real-Time Release Testing (RTRT) has emerged as a defining feature. This regulation-focused article serves as a comprehensive guide for regulatory affairs (RA) professionals, quality assurance (QA), and quality control (QC) experts. It emphasizes the critical need for scenario planning associated with AI model failure and outlines methodologies for fallback release approaches. Regulatory Affairs Context As the sector progresses towards continuous…

KPIs to track success of AI and RTRT adoption across products and sites KPIs to Track Success of AI Tools and Real-Time Release Testing Adoption Across Products and Sites Regulatory Affairs Context In the rapidly evolving landscape of pharmaceutical manufacturing, the integration of artificial intelligence (AI) and real-time release testing (RTRT) has emerged as pivotal to enhancing quality assurance (QA) and quality control (QC) processes. Regulatory authorities such as the FDA, EMA, and MHRA have established specific guidelines and expectations concerning the implementation of these technologies. Understanding how to evaluate their success through key performance indicators (KPIs) is essential for…